"Click" reaction in conjunction with diazeniumdiolate chemistry: Developing high-load nitric oxide donors

Organic Letters

Volumn 12, Issue 19, 2010, Pages 4256-4259

  Oladeinde, Oyebola A ^a   Hong, Sam Y ^a   Holland, Ryan J ^a   MacIag, Anna E ^b   Keefer, Larry K ^a   Saavedra, Joseph E ^b   Nandurdikar, Rahul S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZIDE; AZO COMPOUND; DIAZENIUMDIOLATE; NITRIC OXIDE DONOR;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CYCLIZATION;

AZIDES; AZO COMPOUNDS; CYCLIZATION; MOLECULAR STRUCTURE; NITRIC OXIDE DONORS;

EID: 77957127814     PISSN: 15237060     EISSN: 15237052     Source Type: Journal    
DOI: 10.1021/ol101645k     Document Type: Article

References (28)

1. Hrabie, J. A.; Keefer, L. K. Chem. Rev. 2002, 102, 1135-1154
2. Ignarro, L. J. Angew. Chem., Int. Ed. 1999, 38, 1882-1892
3. Furchgott, R. F. Angew. Chem., Int. Ed. 1999, 38, 1870-1880
4. Moncada, S.; Palmer, R. M. J.; Higgs, E. A. Pharmacol. Rev. 1991, 43, 109-142
5. Miller, M. R.; Megson, I. L. Br. J. Pharmacol. 2007, 151, 305-321
6. Wang, P. G.; Xian, M.; Tang, X.; Wu, X.; Wen, Z.; Cai, T.; Janczuk, A. J. Chem. Rev. 2002, 102, 1091-1134
7. Megson, I. L.; Webb, D. J. Expert Opin. Investig. Drugs 2002, 11, 587-601
8. Maciag, A. E.; Saavedra, J. E.; Chakrapani, H. Anticancer Agents Med. Chem. 2009, 9, 798-803
9. Hong, S. Y.; Saavedra, J. E.; Keefer, L. K.; Chakrapani, H. Tetrahedron Lett. 2009, 50, 2069-2071
10. Liu, J.; Saavedra, J. E.; Lu, T.; Song, J.-G.; Clark, J.; Waalkes, M. P.; Keefer, L. K. J. Pharmacol. Exp. Ther. 2002, 300, 18-25
11. Valdez, C. A.; Saavedra, J. E.; Showalter, B. M.; Davies, K. M.; Wilde, T. C.; Citro, M. L.; Barchi, J. J., Jr.; Deschamps, J. R.; Parrish, D.; El-Gayar, S.; Schleicher, U.; Bogdan, C.; Keefer, L. K. J. Med. Chem. 2008, 51, 3961-3970
12. Nandurdikar, R. S.; Maciag, A. E.; Hong, S. H.; Chakrapani, H.; Citro, M. L.; Saavedra, J. E.; Keefer, L. K. Org. Lett. 2010, 12, 56-59
13. Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Angew. Chem. 2001, 113, 2056-2075
14. Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Angew. Chem., Int. Ed. 2001, 40, 2004-2021
15. Tornoe, C. W.; Christensen, C.; Meldal, M. J. Org. Chem. 2002, 67, 3057-3064
16. For selected reviews, see
17. Meldal, M.; Tornoe, C. W. Chem. Rev. 2008, 108, 2952-3015
18. Moorhouse, A. D.; Moses, J. E. ChemMedChem 2008, 3, 715-723
19. Lutz, J. Angew. Chem., Int. Ed. 2007, 46, 1018-1025
20. Bock, V. D.; Hiemstra, H.; van Maarseveen, J. H. Eur. J. Org. Chem. 2006, 2006, 51-68
21. Kolb, H. C.; Sharpless, K. B. Drug Discovery Today 2003, 8, 1128-1137
22. Rodionov, V. O.; Fokin, V. V.; Finn, M. G. Angew. Chem., Int. Ed. 2005, 44, 2210-2215
23. Nandurdikar, R. S.; Maciag, A. E.; Citro, M. L.; Shami, P. J.; Keefer, L. K.; Saavedra, J. E.; Chakrapani, H. Bioorg. Med. Chem. Lett. 2009, 19, 2760-2762
24. Vsevolod, V. R.; Luke, G. G.; Valery, V. F.; Sharpless, K. B. Angew. Chem., Int. Ed. 2002, 41, 2596-2599
25. Angell, Y.; Burgess, K. Angew. Chem., Int. Ed. 2007, 46, 3649-3651
26. The triazole linkers are considered inert to metabolic transformation. However, the toxicological profile or physiological clearance of the bis-triazole or triazolo-triazole linkers is not reported. The synthesis of such compounds makes them available for such studies.
27. For a review on five-membered heterocyclic compound biotransformation, see
28. Dalvie, D. K.; Kalgutkar, A. S.; Khojasteh-Bakht, S. C.; Obach, R. S.; ODonnell, J. P. Chem. Res. Toxicol. 2002, 15, 269-299